Takeda Manufacturing Singapore Pte Ltd - Main Building
About This Business
Takeda Pharmaceuticals: Global Homepage
* Ethics & Disclosures
* Corporate Governance
* Corporate Sustainability
* Ethics & Disclosures
* Corporate Governance
Search...Search...
Takeda - Global
- EnglishEnglish
- JapaneseJapanese
- Argentina SpanishSpanish
- Australia EnglishEnglish
- Austria GermanGerman
- Belarus RussianRussian
- Belgium EnglishEnglishFrenchFrenchDutchDutch
- Bosnia and Herzegovina BosnianBosnian
- Brazil PortuguesePortuguese
- Bulgaria BulgarianBulgarian
- Canada EnglishEnglishFrenchFrench
- Chile SpanishSpanish
- Mainland China ChineseChinese
- Colombia SpanishSpanish
- Croatia CroatianCroatian
- Czech Republic CzechCzech
- Denmark DanishDanish
- Ecuador SpanishSpanish
- Egypt EnglishEnglish
- Estonia EstonianEstonian
- Finland FinnishFinnish
- France FrenchFrench
- Germany GermanGerman
- Greece GreekGreek
- Hong Kong SAR EnglishEnglishChineseChinese
- Hungary HungarianHungarian
- India EnglishEnglish
- Indonesia IndonesianIndonesian
- Ireland EnglishEnglish
- Israel HebrewHebrew
- Italy ItalianItalian
- Kazakhstan KazakhKazakhRussianRussian
- Korea KoreanKorean
- Latvia LatvianLatvian
- Lithuania LithuanianLithuanian
- Malaysia EnglishEnglish
- Mexico SpanishSpanish
- Netherlands DutchDutch
- New Zealand EnglishEnglish
- Norway NorweiganNorweigan
- Peru SpanishSpanish
- Philippines EnglishEnglish
- Poland PolishPolish
- Portugal PortuguesePortuguese
- Romania RomanianRomanian
- Russia RussianRussian
- Saudi Arabia EnglishEnglishArabicArabic
- Serbia SerbianSerbian
- Singapore EnglishEnglish
- Slovakia SlovakSlovak
- Slovenia SlovenianSlovenian
- South Africa EnglishEnglish
- Spain SpanishSpanish
- Sweden SwedishSwedish
- Switzerland GermanGerman
- Taiwan ChineseChinese
- Thailand ThaiThai
- Turkey TurkishTurkish
- Ukraine UkrainianUkrainian
- United Kingdom EnglishEnglish
- United States EnglishEnglish
- Vietnam EnglishEnglish
Takeda - Global
- EnglishEnglish
- JapaneseJapanese
- Argentina SpanishSpanish
- Australia EnglishEnglish
- Austria GermanGerman
- Belarus RussianRussian
- Belgium EnglishEnglishFrenchFrenchDutchDutch
- Bosnia and Herzegovina BosnianBosnian
- Brazil PortuguesePortuguese
- Bulgaria BulgarianBulgarian
- Canada EnglishEnglishFrenchFrench
- Chile SpanishSpanish
- Mainland China ChineseChinese
- Colombia SpanishSpanish
- Croatia CroatianCroatian
- Czech Republic CzechCzech
- Denmark DanishDanish
- Ecuador SpanishSpanish
- Egypt EnglishEnglish
- Estonia EstonianEstonian
- Finland FinnishFinnish
- France FrenchFrench
- Germany GermanGerman
- Greece GreekGreek
- Hong Kong SAR EnglishEnglishChineseChinese
- Hungary HungarianHungarian
- India EnglishEnglish
- Indonesia IndonesianIndonesian
- Ireland EnglishEnglish
- Israel HebrewHebrew
- Italy ItalianItalian
- Kazakhstan KazakhKazakhRussianRussian
- Korea KoreanKorean
- Latvia LatvianLatvian
- Lithuania LithuanianLithuanian
- Malaysia EnglishEnglish
- Mexico SpanishSpanish
- Netherlands DutchDutch
- New Zealand EnglishEnglish
- Norway NorweiganNorweigan
- Peru SpanishSpanish
- Philippines EnglishEnglish
- Poland PolishPolish
- Portugal PortuguesePortuguese
- Romania RomanianRomanian
- Russia RussianRussian
- Saudi Arabia EnglishEnglishArabicArabic
- Serbia SerbianSerbian
- Singapore EnglishEnglish
- Slovakia SlovakSlovak
- Slovenia SlovenianSlovenian
- South Africa EnglishEnglish
- Spain SpanishSpanish
- Sweden SwedishSwedish
- Switzerland GermanGerman
- Taiwan ChineseChinese
- Thailand ThaiThai
- Turkey TurkishTurkish
- Ukraine UkrainianUkrainian
- United Kingdom EnglishEnglish
- United States EnglishEnglish
- Vietnam EnglishEnglish
Takeda Pharmaceuticals: Global Homepage
=======================================
FY2025 Q1 Financial Results
FY2025 Q1 Financial Results
Recent News
### Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025 Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025 September 8, 2025
### U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease September 5, 2025
### Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression July 30, 2025
### Takeda Receives FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices to Simplify HYQVIA® Administration Takeda Receives FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices to Simplify HYQVIA® Administration July 21, 2025
View All
We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.
Better Health, Brighter Future
Better Health, Brighter Future
### Join Us ### Join Us
Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world.
Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world.
FIND OUT MORE FIND OUT MORE
### Investors ### Investors
Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth.
Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth.
FIND OUT MORE FIND OUT MORE
### R&D ### R\&D
Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.
Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.
FIND OUT MORE FIND OUT MORE
Our Areas of Focus
Our Areas of Focus
### Gastrointestinal and Inflammation ### Gastrointestinal and Inflammation Understanding and addressing life-limiting gastrointestinal and inflammatory diseases Understanding and addressing life-limiting gastrointestinal and inflammatory diseases
### Rare Diseases ### Rare Diseases Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders
### Plasma-Derived Therapies ### Plasma-Derived Therapies Improving the lives of patients with rare and complex chronic diseases through innovation in plasma Improving the lives of patients with rare and complex chronic diseases through innovation in plasma
### Oncology ### Oncology Aspiring to cure cancer, with inspiration from patients and innovation from everywhere Aspiring to cure cancer, with inspiration from patients and innovation from everywhere
### Neuroscience ### Neuroscience Driving medical innovation for patients with neurological diseases Driving medical innovation for patients with neurological diseases
### Vaccines ### Vaccines Addressing unmet global health needs through vaccine development against infectious diseases Addressing unmet global health needs through vaccine development against infectious diseases
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
View Vendor Details
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.